Effects of rasagiline on the progression of nonmotor scores of the MDS‐UPDRS

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8257|30|4|589-592

ISSN： 0885-3185

Source： MOVEMENT DISORDERS, Vol.30, Iss.4, 2015-04, pp. : 589-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Handling missing values in the MDS‐UPDRS

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 12, 2015-10 ,pp. : 1632-1638

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proposing a Parkinson's disease–specific tremor scale from the MDS‐UPDRS

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 8, 2015-07 ,pp. : 1139-1143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Minimum Data Set Plus (MDS+) Scores Compared with Scores from Five Rating Scales

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 3, 1996-03 ,pp. : 305-309

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double‐blind, placebo‐controlled, multicenter study

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 7, 2015-06 ,pp. : 1009-1009

John Wiley & Sons Inc

Access to resources Recommend Favorite

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non‐demented Parkinson's disease patients

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 8, 2015-08 ,pp. : 1184-1191

John Wiley & Sons Inc

Access to resources Recommend Favorite